82143-002-01 : NDC 2026 Code

82143-002-01 : Bevacizumab-tnjn ( Avzivi )

Additionally :

You can get information about “82143-002-01” NDC code in 82143-002-01 in HTML format

HTML | 82143-002-01 in TXT (Plain Text) format

TXT | 82143-002-01 in PDF (Portable Document Format)

PDF | 82143-002-01 in XML format

XML formats.

NDC Code : 82143-002-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "82143-002-01",
    "PackageDescription": "1 VIAL in 1 CARTON (82143-002-01)  / 16 mL in 1 VIAL",
    "NDC11Code": "82143-0002-01",
    "ProductNDC": "82143-002",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Avzivi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Bevacizumab-tnjn",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20250101",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761198",
    "LabelerName": "Bio-Thera Solutions, Ltd.",
    "SubstanceName": "BEVACIZUMAB-TNJN",
    "StrengthNumber": "400",
    "StrengthUnit": "mg/16mL",
    "Pharm_Classes": "Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250101",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}